It has been shown that SB28 glioma cells do not express PD-L1 under basal conditions, but PD-L1 expression can be induced in vitro by IFN-g.22 Why anti-PD-L1 was more effective than dual CTLA-4/PD-1 blockade is unknown, but there are several possible mechanisms that distinguish these therapies. Here, CD274 is linked to glioma.